NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
Amber SPAInsulin degludec
(100units/mL) 		Endocrine system, Intermediate- and long-acting insulins, 06.01.01.02
Amber SPAInsulin degludec
(200units/mL) 		Endocrine system, Intermediate- and long-acting insulins, 06.01.01.02
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Insulin  Insulin Degludec Endocrine System, Insulins, Insulins, Long-Acting
Diabetes Mellitus And Hypoglycaemia, Diabetes Mellitus
Insulin  Insulin Degludec With Liraglutide Endocrine System, Insulins, Insulins, Long-Acting
Diabetes Mellitus And Hypoglycaemia, Diabetes Mellitus
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
APC Bulletin 5 (March 2023): Insulin Degludec (Tresiba®)
CAS Alert Dec 2023 Potential for inappropriate dosing of insulin when switching insulin degludec (Tresiba) products
MHRA Drug Safety Update (April 2013) - Insulin degludec (Tresiba▼): available in additional higher strength
MHRA Drug Safety Update (April 2013) - Insulin degludec (Tresiba▼): available in additional higher strength